7YW1 image
Entry Detail
PDB ID:
7YW1
Title:
crystal structure of UBE2O
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2022-08-20
Release Date:
2023-08-30
Method Details:
Experimental Method:
Resolution:
3.27 Å
R-Value Free:
0.30
R-Value Work:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:(E3-independent) E2 ubiquitin-conjugating enzyme UBE2O
Chain IDs:A, B
Chain Length:928
Number of Molecules:2
Biological Source:Trametes pubescens
Ligand Molecules
Primary Citation
Structural insights into the biochemical mechanism of the E2/E3 hybrid enzyme UBE2O.
Structure 33 274 288.e4 (2025)
PMID: 39740670 DOI: 10.1016/j.str.2024.12.002

Abstact

The E2/E3 hybrid enzyme UBE2O plays important roles in key biological events, but its autoubiquitination mechanism remains largely unclear. In this study, we determined the crystal structures of full-length (FL) UBE2O from Trametes pubescens (tp) and its ubiquitin-conjugating (UBC) domain. The dimeric FL-tpUBE2O structure revealed interdomain interactions between the conserved regions (CR1-CR2) and UBC. The dimeric intermolecular and canonical ubiquitin/UBC interactions are mechanistically important for UBE2O functions in catalyzing the formation of free polyubiquitin chains and substrate ubiquitination. Beyond dimerization, autoubiquitination within the CR1-CR2 domain also regulates tpUBE2O activity. Additionally, we show that tpUBE2O catalyzes the formation of all seven types of polyubiquitin chains in vitro. The CR1-CR2/UBC and canonical ubiquitin/UBC interactions are important for the polyubiquitination of AMP-activated protein kinase α2 (AMPKα2) by human UBE2O (hUBE2O), which leads to tumorigenesis. These structural insights lay the groundwork for understanding UBE2O's mechanisms and developing structure-based therapeutics targeting UBE2O.

Legend

Protein

Chemical

Disease

Primary Citation of related structures